Literaturverzeichnis

1.Kirste, G.: Stand und Entwicklung der Nierentransplantation
Zentralbl Chir 118: 113-117 (1993)

2.May, G.: Gegenwart und Perspektiven der Nierentransplantation
Z-Gesamte-Inn-Med 41: 294-297 (1986)

3.Lütkes, P., Franke, G., Witzke, O., Zimmermann, U., Kohnle, M., Philipp, T., Heemann, U.: Lebensqualität nach Nierentransplantation. Einfluß neuer immunsuppressiver Maßnahmen.Zentralbl-Chir. 124: 90-94 (1999)

4.Christensen, A.J., Holman Jr., J.M., Turner, C.W., Smith, T.W., Grant, M.K., DeVault Jr., G.A.: A Prospective Study of Quality of Life in End-Stage Renal Disease: Effects of Cadaveric Renal TransplantationClin. Transplantation 5: 40-47 (1991)

5.Linker, H.:, Langzeitprognose nach NierentransplantationVersicherungsmedizin 51: 69-70 (1999)

6.Yoshimura,. , Oka , T., Nakane, Y., Aikawa, I., Okamoto, M., Akioka, K., Nakamura, K., Ushigome, H., Kadotani,., Ohmori, Y.: Long-Term Results and Complications of Living Related Kidney Transplantation in a Single CenterTransplant-Proc. 34: 1675-1677 (2002)

7. Howard, R.J., Reed, A.I., Hemming, A.W., Van der Werf, W.J., Patton, P.R., Pfaff, W.W., Srinivas, T.R., Scornik, J.C.: Graft Loss and Death: Changing Causes After Kidney Transplantation
Transplant-Proc 33: 3416 (2001)

8.Tan, B.H.: Infections in Transplant Recipients in Developing CountriesTransplant-Proc. 32: 1501-1502 (2000)

9.Ossareh, S., Ghods, A.J.: Results of Renal Transplantation in the Elderly: Single Center ExperienceTransplant-Proc. 34: 2068-2069 (2002)

10.Frei, U., Schindler, R.: Probleme im Langzeitverlauf nach Nierentransplantation.
Internist 36: 263-269 (1995)

11.Ivens, K., Aker, S., Grabensee, B., Heering, P.: Inzidenz von Risikofaktoren und kardiovaskulären Komplikationen bei Patienten nach Nierentransplantation
Med-Klin. 94: 478-84 (1999)

12.Schindler, R., Schneider, U., Frei, U.: Die kardiale Situation des Nierentransplantierten
Nieren- und Hochdruckkrankheiten29: 440-444 (2000)

13.Fabrega, A., Matas, A.J., Payne, W.D., Fryd, D.S., Dunn, D.L., Sutherland, D.E.R., Najarian, J.S .: Ten- to 20-year follow-up of 123 consecutive HLA-identical living-related kidney transplants from the pre-cyclosporine eraClin Transplantation 4: 142-152 (1990)

14. Kozlowska-Boszko, B., Lao, M., Gaciong, Z., Sicinska, J., Durlik, M., Morzycka, M., Szmidt, J., Rowinski, W.: Chronic Rejection as a Risk Factor for Deterioration of Renal Allograft Function Following PregnancyTransplant-Proc. 29: 1522-1523 (1997)

15.Margreiter, R.: Die Entwicklung der Nierentransplantation
Nieren und Hochdruckkrankheiten32: 274-279 (2003)

16.Schmouder, R.L.: Immunsuppressive Therapies for the Twenty-First CenturyTransplant-Proc. 32: 1463-1467 (2000)

17.Tarantino, A., Montagnino, G., Cesana, B., Berardinelli, L., Passerini, P., Campise, M., Aroldi, A., Ponticelli, C.: Renal Transplantation From Older DonorsTransplant-Proc. 33: 3769-3770 (2001)

18.Friedrich, J., Albrecht, K.H., Claus, M., Eigler, F.W.: Einfluß von Spender- und Empfängeralter auf die Ergebnisse der Nierentransplantation
Dtsch-Med-Wochenschr. 14: 467-471 (1995)

19.Sancho, A., Crespo, J.F., Gorriz, J.L., Gavela, E., Cano, A., Pallardo, L.M.: Age as a Risk Factor in Renal TransplantationTransplant-Proc. 34: 355 (2002)

20.Kyllönen, L., Koskimies, S., Salmela, K.: Renal Transplant Recipients With Graft Survival Longer Than 20 Years: Report on 107 CasesTransplant-Proc. 33: 2444-2445 (2001)

21.Meier-Kriesche, H.-U., Ojo, A.O., Arndorfer, J.A., Port, F.K., Magee, J.C., Leichtmann, A.B., Punch, J.D., Kaplan, B.: Recipient Age as an Independent Risk Factor for Chronic Renal Allograft FailureTransplant-Proc. 33: 1113-1114 (2001)

22.Herrero, J.C., Gutiérrez, E., Martínez, A., González, E., Morales, E., Munoz, M.A., Valentín, M., Bueno, B., Praga, M., Hernández, E., Morales, J.M., Rodicio, J.L., Andrés, A.: Results of Kidney Transplantation in Recipients Over 70 Years of Age: Experience at a Single CenterTransplant-Proc. 35: 1675-1676 (2003)

23.Andres, A., Herrero, J.C., Gonzales, E., Morales, E., Morales, J.M., Diaz, R., Polo, G., Leiva, O., Rodicio, J.L., Praga, M .: Long-Term Results of Renal Transplantation in Elderly Cadaver Donor Recipients 65 Years Old or OlderTransplant-Proc. 34: 356-357 (2002)

24.Wilms, H., Kirste, G., Hörl, W.H., Schollmeyer, P., Farthmann, E.H.: 20 Jahre Nierentransplantation – Erfahrungen eines Klinikums
Fortschr-Med 20: 415-418 (1991)

25.Mathew, T.H., McDonald, S.P., Russ, G.R .: Donor and Recipient Risk Factors and Choice of Immunosuppression Determine Long-Term Outcome in Renal TransplantationTransplant-Proc. 33: 3400-3402 (2001)

26.Sarparanta, T., Höckerstedt, K., Ahonen, J., Eklund, B., Salmela, K., Petterson, E., Koskimies, S., von Willebrand, E.: The Effect of Long Cold Ischemia Time on Primary and Secondary Cadaver Renal AllograftsTransplant-Proc. 18: 80-83 (1986)

27.Lam, M.F., Li, F.K., Choy, B.Y., Tang, S., Lo, W.K., Lui, S.L., Chu, S.M., Tam, P.C., Chan, T.M., Lai, K.N.: The Impact of the Establishment of a Multiorgan Transplantation Program on Cold Ischemia Time and Delayed Graft Function in Renal TransplantationTransplant-Proc. 32: 1611-1612 (2000)

28.Mota, A., Figueiredo, A., Cunha, M.F.X., Bastos, M., Pratas, J., Furtado, L.: Risk Factors for Acute Rejection in 806 Cyclosporin-Treated Renal Transplants: A Multivariate AnalysisTransplant-Proc. 35: 1061-1063 (2003)

29.Degawa, H., Matsuno, N., Iwamoto, H., Hama, K., Nakamura, Y., Narumi, Y., Kikuchi, K., Uchiyama, M., Kozaki, K., Nagao, T.: Primary Nonfunctioning Grafts in Cadaveric Kidney TransplantationTransplant-Proc. 32: 1903-1904 (2000)

30.Sienko, J., Wisniewska, M., Ostrowski, M., Ciechanowski, K., Safranow, K., Chudyk, A., Fronczyk, A., Rozanski, J., Kaminski, M., Sulikowski, T., Romanowski, M., Pabisiak, K., Paczkowski, M., Mizerski, A.: Impact of Selected Factors on Early Graft Function in Patients After Renal TransplantationTransplant-Proc. 35: 2167-2169 (2003)

31.Arrazola, L., Sozen, H., Humar, A., Papalois, V., Uknis, M., Matas, A.J.: Both Immunologic and Nonimmunologic Factors are Risks for Long-Term Graft Survival – A Multivariate AnalysisTransplant-Proc. 32: 1831 (2000)

32.Sanfilippo, F., Vaughn, W.K., Bollinger, R.R., Spees, E.K.: Comparative Effects of Pregnancy, Transfusion, and prior Graft Rejection on Sensitization and Renal Transplant ResultsTransplantation 34: 360-366 (1982)

33.Iwaki, Y., Cecka, J.M., Terasaki, P.I.: The Transfusion Effect in Cadaver Kidney Transplants – Yes or NoTransplantation 49: 56-59 (1990)

34.Miura, S., Okazaki, H., Sato, T., Amada, N., Ohashi, Y., Sato, K.: Long-Term Results of Spousal Renal Donor Transplants With Donor-Specific Blood TransfusionsTransplant Proc. 33: 3417-3419 (2001)

35.Takemoto, S.K., Bradley, B.A., Gjertson, D.W., Cho, Y.W., Cecka, J.M.: Pregnancy: A Two-Edged SwordTransplant-Proc. 33: 471-472 (2001)

36.Deierhoi, M.H., Barger, B.O., Hudson, S.L., Shroyer, T.W., Diethelm, A.G.: The Effect of Erythropoietin and Blood Transfusions on Highly Sensitized Patients on a Single Cadaver Renal Allograft Waiting ListTransplantation 53: 363-368 (1992)

37.McKenna, R.M., Takemoto, S.K., Terasaki, P.I .: Anti-HLA Antibodies after solid Organ TransplantationTransplantation 69: 319-326 (2000)

38.Kokado, Y., Takahara, S., Hatori, M., Ichimaru , , I., Wang, J.D., Miki, T., Okuyama, A.: Acute Rejection Episodes Predict Long-Term Renal Transplantation SurvivalTransplant-Proc. 29: 1537-1540 (1997)

39.Castilho, C., Piovesan, F., Michelon, T., Seelig, D., Pozza, R., Santos, A.F., Bittar, A.E., Keitel, E., Goldani, J.C., Neumann, J., Garcia, V.D .: Primary Nonfunctioning Graft in Cadaveric Renal TransplantationTransplant-Proc. 33: 3785-3786 (2001)

40.Speiser, D.E., Frick, T.W., Goumaz, C., Opelz, G., Jeannet, M.: Immunologische Aspekte der Nierentransplantation in der Schweiz 1981-1992
Schweiz Med Wochenschr 125: 1573-1582 (1995)

41.Gjertson, D.W., Terasaki, P.I.: The Large Center Variation in Half-Lives of Kidney TransplantsTransplantation 53: 357-362 (1992)

42. Briganti, E.M., Wolfe, R., Russ, G.R., Eris, J.M., Walker, R.G., McNeil, J.J .: Graft loss following renal transplantation in Australia: is there a centre effect?Nephrol Dial Transplant 17: 1099-1104 (2002)

43.Kerman, R.H., Kimball, P.M., van Buren, C.T., Lewis, R.M., Kahan, B.D.: Possible Contribution of Pretransplant Immune Responder Status to Renal Allograft Survival Differences of Black versus White RecipientsTransplantation 51: 338-342 (1991)

44.Scantlebury, V., Gjertson, D., Eliasziw, M., Terasaki, P., Fung, J., Shapiro, R., Donner, A., Starzl, T.E.: Influence of HLA and CREG Matching in African-American Primary Cadaver Kidney Recipients: UNOS 1991-1995Transplant-Proc. 29: 3733-3736 (1997)

45.Opelz, G., Mytilineos, J., Scherer, S., Schwarz, V.: Clinical Implications of DNA Typing in Organ TransplantationTransplant-Proc. 29: 1524-1527 (1997)

46.Meester, J., Persijn, G., Wujciak, T., Opelz, G., Vanrenterghem, Y .: The new Eurotransplant kidney allocation SystemTransplantation 66: 1154-1159 (1998)

47.Wujciak, T., Opelz, G.: Matchability as an Important Factor for Kidney Allocation According to the HLA MatchTransplant-Proc. 29: 1403-1405 (1997)

48.Persijn, G.G., Smits, J.M.A., Smith, M., Frei, U.: Five-Year Experience With the New Eurotransplant Kidney Allocation System, 1996 to 2001Transplant-Proc. 34: 3072-3074 (2002)

49.Voiculescu, A., Ivens, K., Sandmann, W., Grabensee, B.: Lebendnierenspende und -transplantation. Hohe Transplantatüberlebensraten bei kalkulierbarem Risiko
Klinikarzt 32: 355-359 (2003)

50.Hillebrand, G.F., Theodorakis, J., Illner, W.D., Stangl, M., Ebeling, F., Gutmann, Th., Schneewind, K.A., Land, W.: Lebendspende bei Nierentransplantation – Renaissance durch nicht verwandte Spender?
MMW-Fortschr.Med. 42: 798-799 (2000)

51.Cecka, J.M., Terasaki, P.I.: Living Donor Kidney Transplants: Superior Success Rates Despite HistoincompatibilitiesTransplant-Proc. 29: 203 (1997)

52.Alfani, D., Pretagostini, R., Rossi, M., Poli, L., Bruzzone, P., Colonello, M., De Simone, P., Berloco, P., Persijn, G., Smits, J., Cortesini, R.: Living Unrelated Kidney Transplantation: A 12-Year Single Center ExperienceTransplant-Proc. 29: 191-194 (1997)

53.Duquesnoy, R.J.: HLAMatchmaker: A molecularly based Algorithm for Histocompatibility Determination. I. Description of the Algorithm.Hum-Immunol. 63: 339-352 (2002)

54.Duquesnoy, R.J., Marrari, M .: HLAMatchmaker: A molecularly based Algorithm for Histocompatibility Determination. II. Verification of the Algorithm and Determination of the relative immunogenicity of amino acid triplet-defined epitopes.Hum-Immonol. 63: 353-363 (2002)

55.Duquesnoy, R.J.: HLAMatchmaker: A Molecularly Based Donor Selection Algorithm for Highly Alloimmunized PatientsTransplant-Proc. 33: 493-497 (2001)

56.Duquesnoy, R.J.: Is Histocompatibility Testing Needed for Composite Tissue Transplantation?Transplant-Proc. 30: 2724-2728 (1998)

57.Terasaki, P.I., McClelland, J.D., Park, M.S., McCurdy, B.: Microdroplet Lymphocyte Cytotoxicity Test; In: Ray, J.G., Hare, D.B., Pedersen, P.D., Kayhoe, D.E. (Eds.)Manual of Tissue Typing Techniques. DHEW Publication no. (NIH) 75-545, p. 67-74 (1974)

58. Moldenhauer, A., Kohlhaus, R., Salama, A .: An Extended Lymphocytotoxicity Test for Patients Treated with Lymphocytotoxic AntibodiesVox-Sang. 78: 250-253 (2000)

59.Reddy, K.S., Clark, K.R., Cavanagh ,G ., Forsythe, J.L.R., Proud, G., Taylor, R.M.R.: Successfull Renal Transplantation With a Positive T-Cell Cross Match Caused by IgM AntibodiesTransplant Proc. 27: 1042-1043 (1995)

60.Wonigeit, K.: Immunsuppression bei Organtransplantation
Internist 37: 229-239 (1996)

61.May, G.: Immunsuppression und Abstoßungsbehandlung nach Nierentransplantation
Urologe 33: 365-369 (1994)

62.Kaden, J., Strobelt, V., May, G.: Short and Long-Term Results after Pretransplant High-Dose Single ATG-Fresenius Bolus in Cadaveric Kidney TransplantationTransplant-Proc. 30: 4011-4014 (1998)

63.Oesterwitz, H., May, G., Mueller, P., Strobelt, V., Seeger, W., Seibt, F., Horlbeck, R., Hansen, Ch.: Vierfach-Immunsuppression bei präsensibilisierten Patienten allogener Leichennierentransplantate
Z-Urol-Nephrol. 83: 1-8 (1990)

64.Kaden, J., Strobelt, V., Oesterwitz, H., Groth, J., May, G., Eichler, C.: Monitoring of Renal Allograft Rejection with Fine Needle Aspiration Biopsy and Serum C-Reactive Protein DeterminationsTransplant-Proc. 19: 1657 (1987)

65.Hanssen, Ch., Müller, P., Seibt, F., Oesterwitz, H., May, G., Strobelt, V., Kaden, J., Ditscherlein, G., Scholz, D.: Einsatz von OKT-3 bei der Rejektionsbehandlung nach Nierentransplantation
Z. Urol. Nephrol. 83: 165-170 (1990)

66.Rodey, G.E., Neylan, J.F., Whelchel, J.D., Revels, K.W., Bray, R.A.: Epitope Specificity of HLA Class I Alloantibodies – 1. Frequency Analysis of Antibodies to Private versus Public Specifities in Potential Transplant RecipientsHum-Immunol. 39: 272-280 (1994)

67.Brunkhorst, R., Schlitt, H.J.: Nierentransplantation – Indikationen, Ergebnisse, Vor- und Nachsorge
Internist 37: 264-271 (1996)

68.Opelz, G., Wujciak, T., Back, D., Mytilineos, J., Schwarz, V., Albrecht, G.: Einfluß der HLA-Kompatibilität auf die Nierentransplantation
Infusionsther-Transfusionsmed. 21: 198-202 (1994)

69.Opelz, G.: Factors Influencing Long-Term Graft LossTransplant-Proc. 32: 647-649 (2000)

70.Opelz, G., Wujciak, T., Döhler, B.: Is HLA Matching Worth the Effort?Transplant-Proc. 31: 717-720 (1999)

71.Opelz, G.: New Immunsuppressants and HLA MatchingTransplant-Proc. 33: 467-468 (2001)

72.Klehr, H.U., Jacobs, U., Miersch, W.D., Molitor, D.: Vergleich der Nierentransplantation mit und ohne Berücksichtigung der HLA-Typisierung
Dtsch.med.Wochenschr. 121: 434-441 (1996)

73.Klein, T., Shapira, Z., Bar Nathan, N., Shaharabani, E., Or , H., Zakai, C., Shabtei, E., Yussim, A.: Lack of Correlation Between HLA Match and Long-Term Survival in Living Donor Kidney TransplantationTransplant-Proc. 32: 692-693 (2000)

74.Hata, Y., Cecka, M., Takemoto, S., Ozawa, M., Cho, Y., Terasaki, P.I.: Effects of changes in the criteria for nationally shared kidney transplants for HLA-matched PatientsTransplantation 65: 208-212 (1998)

75.Terasaki, P.I., Cho, Y., Takemoto, S., Cecka, M., Gjertson, D.: Twenty-Year Follow-up on the Effect of HLA Matching on Kidney Transplant Survival and Prediction of Future Twenty-Year SurvivalTransplant-Proc. 28: 1144-1145 (1996)

76.Takemoto, S., Cecka, J.M., Gjertson, D.W., Terasaki, P.I.: Six-Antigen-Matched Transplants. Causes of FailureTransplantation 55: 1005-1008 (1993)

77.Lee, P.C., Lee, P.H., Shaw, C.K., Takemoto, S.K., Gjertson, D.W., Siauw, P.A., Terasaki, P.I .: HLA Epitopes for Kidney AllocationTransplant-Proc. 30: 3496-3497 (1998)

78.Papassavas, A.C., Iniotaki-Theodoraki, A., Boletis, J., Kostakis, A., Stavropoulos-Giokas, C .: Development of Anti-HLA-Antibodies Against Intra-CREG-Mismatches in Renal Transplant RecipientsTransplant-Proc. 31: 757-759 (1999)

79.Fernandez-Fresnedo, G., Pastor, J.M., Ruiz, J.C., Cotorruelo, J.G., Setien, M.A., Lopez-Hoyos, M., Arias, M.: Differences in Anti-CREG Antibody Formation between Transplanted and Nontransplanted Renal PatientsTransplantation 67: 1188-1190 (1999)

80.Rodey, G.E., Revels, K., Fuller, T.C.: Epitope Specificity of HLA Class I Alloantibodies II. Stability of Cross-Reactive Group Antibody Patterns over extended Time PeriodsTransplantation 63: 885-893 (1997)

81.Zafar, M.N., Abbas, K., Muzaffer, R., Hafiz, S., Hussain, Z., Naqvi, A., Rizvi , S.A.: Impact of CREG Matching on Renal Allograft Survival in One Haplotype Matched TransplantsTransplant-Proc. 32: 1838 (2000)

82.Crowe, D.O.: The effect of cross-reactive epitope group matching on allocation and sensitizationClin Transplant 17 (Suppl. 9): 13-16 (2003)

83.Wujciak, T., Opelz, G.: Evaluation of HLA-Matching for CREG Antigens in EuropeTransplantation 68: 1097-1099 (1999)

84.Starzl, T.E., Eliasziw, M., Gjertson, D., Terasaki, P.I., Fung, J.J., Trucco, M., Martell, J., McMichael, J., Scantlebury, V., Shapiro, R., Donner, A .: HLA and Cross-Reactive Antigen Group Matching for Cadaver Kidney AllocationTransplantation 64: 983-991 (1997)

85.Stobbe, I., Van Der Meer-Prins, E.M.W., De Lange, P., Oudshoorn, M., De Meester, J., Doxiadis, I.I.N., Claas, F.H.J.: Cross-Reactive Group Matching does not lead to a better Allocation and Survival of Donor KidneysTransplantation 70: 157-161 (2000)

86.Thompson, J., Thacker, L., Takemoto, S.: CREG Matching for First Kidney Transplants Performed by SEOPF Centers Between October 1987 and September 1995: An Analysis of Outcome and Prospective BenefitTransplant-Proc. 29: 1435-1438 (1997)

87.Papassavas, A.C., Stavropoulos-Giokas, C., Boletis, J., Iniotaki-Theodoraki, A., Ioannou, S., Stravoskoufi, P., Kostakis, A.: Epitope Analysis of the HLA Class I Specific Antibodies: A Useful Tool for the Detection of the Acceptable Mismatches for Highly Sensitized PatientsTransplant-Proc. 34: 2053-2055 (2002)

88.Takemoto, S., Terasaki, P.I., Park, M.S., Clark, B.D.: Effect of Mismatching Serologically Defined Residues on Kidney Transplant SurvivalTransplant-Proc. 24: 1266-1268 (1992)

89.Duquesnoy, R.J., White, L.T., Iwaki, Y., Vanek, M.: Multiscreen Analysis of High PRA Sera for Antibodies Towards Public and Private Class I Antigens: Implications for Computer-Predicted Acceptable Donors for Kidney Transplant CandidatesTransplant-Proc. 23: 387-388 (1991)

90.Duquesnoy, R.J., White, L.T., Fierst, J.W., Vanek, M., Banner, B.F., Iwaki, Y., Starzl, T.E.: Multiscreen Serum Analysis of Highly Sensitized Renal Dialysis Patients for Antibodies Toward Public and Private Class I HLA DeterminantsTransplantation 50: 427-437 (1990)

91.Duquesnoy, R.J., Marrari, M.: Determination of HLA-A ,B Residue Mismatch Acceptability for Kidneys Transplanted into Highly Sensitized PatientsTransplantation 63: 1743-1751 (1997)

92.Terasaki, P.I., Takemoto, S., Park, M.S., Cecka, J.M., Mickey, M.R .: Molecular HLA MatchingTransplant-Proc. 23: 365-367 (1991)

93.Takemoto, S., Terasaki, P.I.: HLA Compatibility can be Predicted by Matching Only Three Residues with Outward Oriented SidechainsTransplant-Proc. 28: 1264-1266 (1996)

94.Adib, M., Abkar Shahnazar, E.: Evaluation of Antibody Synthesis Due to Blood Transfusion in 314 Patients From the Isfahan (Iran) Transplantation CenterTransplant-Proc. 32: 598 (2000)

95.Langer, K., Buchholz, B., Raidt, H., Graefe, U., Lison, A.-E.: Langzeitergebnisse nach Nierentransplantation
Med-Klin. 85: 637-642 (1990)

96.Terasaki, P.I., Cecka, J.M., Gjertson, D.W., Takemoto, S.: High Survival Rates of Kidney Transplants from Spousal and Living Unrelated DonorsN-Engl-J-Med. 333: 333-336 (1995)

97.Opelz, G., Vanrenterghem, Y., Kirste, G., Gray, D.W.R., Horsburgh, T., Lachance, J.-G., Largiader, F., Lange, H., Vujaklija-Stipanovic, K., Alvarez-Grande, J., Schott, W., Hoyer, J., Schnuelle, P., Descoeudres, C., Ruder, H., Wujciak, T., Schwarz, V.: Prospective Evaluation of Pretransplant Blood Transfusions in Cadaver Kidney RecipientsTransplantation 63: 964-967 (1997)

98.Hardy, M.A., Reed, E., Suciu-Foca, N.: Antiidiotypic antibodies and pretreatment with blood transfusions in organ transplantationClin Transplantation (Spec. issue) 5: 501-504 (1991)

99.Dewar, P.J., Murray, S., Wilkinson, R., Elliott, R.W., Ward, M.K., Proud, G., Taylor, R.M.R .: A New Finding Relating to Transfusion and Renal TransplantsTransplantation 29: 379-380 (1980)

100.Heise, E.R., Thacker, L.R., MacQueen, J.M., Peters, T.G .: Repeated HLA mismatches and second renal graft survival in centers of the South-eastern Organ Procurement FoundationClin Transplantation 10: 579-585 (1996)

101.Mariat, C., Alamartine, E., De Filippis, J.P., Deprele, C., Le Petit, J.C., Goure, D., Berthoux, F.: Effect of HLA Semi-Identical Pretransplant Blood Transfusion on Renal Allograft OutcomeTransplant-Proc. 32: 381-383 (2000)

102.Fernandez-Fresnedo, G., Pastor, J.M., Lopez-Hoyos, M., Ruiz, J.C., Zubimendi, J.A., Gonzalez-Cotorruelo, J., Rodrigo, E., De Francisco, A.L.M., Arias, M.: Relationship of donor-specific class-I anti-HLA antibodies detected by ELISA after kidney transplantation on the development of acute rejection and graft survivalNephrol Dial Transplant 18: 990-995 (2003)

103.Doxiadis, I.I.N., de Lange, P., D´Amaro, J., de Meester, J., Schreuder, G.M.T., Claas, F.H.J .: Repeated HLA Mismatches in Cadaveric Renal Transplantation: Is It Safe to Transplant?Transplant-Proc. 29: 1408-1409 (1997)

104.Coupel, S., Giral-Classe, M., Karam, G., Morcet, J.F., Dantal, J., Cantarovich, D., Blancho, G., Bignon, J.D., Daguin, P., Soulillou, J.P., Hourmant, M.: Ten-year survival of second kidney transplants : Impact of immunologic factors and renal function at 12 monthsKidney Int64: 674-680 (2003)

105.Opelz, G., Terasaki, P.I .: Second Kidney Transplants and PresensitizationTransplant-Proc. 4: 743-748 (1972)

106.Arndorfer, J.A., Meier-Kriesche, H.U., Ojo, A.O., Gruber, S.A., Cibrik, D.M., Lake, K.D., Kaplan, B., Leichtman, A.B.: Time to First Graft Loss as a Risk Factor for Second Renal Allograft LossTransplant-Proc. 33: 1188-1189 (2001)

107.Nanri ,., Tanabe, K., Ishida, H., Tokumoto, T., Shinmura, H., Toma, H.: Poor Graft Survival in Patients Historically Positive for Antidonor Antibody After Living Related Renal TransplantationTransplant-Proc. 34: 1583 (2002)

108.Torrecilhas, A.C.T., Medina, J.O.P., Panajotopoulos, N., Moura, L.A.R., Gerbase-DeLima, M .: Detection and Clinical Significance of Lymphocytotoxic Antibodies Following Renal TransplantationTransplant-Proc. 34: 482-483 (2002)

109.Worthington, J.E., Martin, S., Dyer, P.A., Johnson, R.W.G .: An Association Between Posttransplant Antibody Production and Renal Transplant RejectionTransplant-Proc. 33: 475-476 (2001)

110.Piazza, A., Poggi, E., Borrelli, L., Valeri, M., Buonomo, O., Servetti, S., Adorno, D., Casciani, C.U .: Relevance of Posttransplant HLA Class I and Class II Antibodies on Renal Graft OutcomeTransplant-Proc. 33: 478-480 (2001)

111.Goulmy, E., Stijnen, T., Groenewoud, A.F., Persijn, G.G., Blokland, E., Pool, J., Paul, L.C., Van Rood, J.J.: Renal Transplant Patients Monitored by the Cell-Mediated Lympholysis AssayTransplantation 48: 559-563 (1989)

112.Schönemann, C., Groth, J., Leverenz, S., May, G.: HLA Class I and II Antibodies – Monitoring Before and After Kidney Transplantation and Their Clinical RelevanceTransplantation 65: 1519-1522 (1998)

113.Suberbielle-Boissel, C., Legendre, C., Meunier, D., Kreis, H., Charron, D., Raffoux, C.: Anti-HLA Sensitization Against Graft Specificities After Kidney Transplantation : Use of PRA-Stat ELISATransplant-Proc. 32: 418 (2000)

114.Norman, P.J., Harmer, A.W., Koffman, C.G., Vaughan, R.W.: Presence of IgG HLA Antibodies in Patients with Long-Surviving Renal AllograftsTransplant-Proc. 27: 999-1000 (1995)

115.Christiaans, M., van den Berg-Loonen, E., Ten Haaft, A., Nieman, F., van Hooff, J.: Effect of Flow Cytometry, Complement-Dependent Cytotoxicity, and Auto Cross Match on Cadaveric Renal Transplant OutcomeTransplant-Proc. 27: 1028-1030 (1995)

116.Vaidya, S., Orchard, P., Haneke, R., Fish, J .: Primary Nonfunction and Preformed Anti-HLA AntibodiesTransplant-Proc. 27: 1033-1035 (1995)

117.Guttmann, R.D.: Delayed Graft Function, Rejection, and Long-Term PrognosisTransplant-Proc. 32: 1453 (2000)

118.Smit, J.A., Stark, J.H., Margolius, L., Thomson, P., Botha, J.R., Meyers, A.M., Myburgh, J.A.: Preformed Antibodies in Predicting Clinical Renal Graft OutcomeTransplant-Proc. 23: 413-414 (1991)

119.Kandaswamy, R., Gillingham, K., Humar, A., Payne, W.D., Dunn, D.L., Sutherland, D.E.R., Najarian, J.S., Matas, A.J.: Impact of HLA-ABDR Match on Chronic Rejection in Kidney TransplantsTransplant-Proc. 33: 1292 (2001)

120.Kandaswamy, R., Humar, A., Payne, W.D., Dunn, D.L., Sutherland, D.E.R., Matas, A.J.: Risk Factors for Kidney Transplant Acute Rejection: A Multivariate AnalysisTransplant-Proc. 33: 1112 (2001)

121.Mota, A., Figueiredo, A., Macario, F., Cunha, F.X., Freitas, L., Parada, B., Bastos, C., Furtado, L .: Risk Factors for Chronic Graft Dysfunction in 918 Renal TransplantsTransplant-Proc. 35: 1064-1065 (2003)

122.Fernandez-Fresnedo, G., Pastor, J.M., Lopez-Hoyos, M., de Francisco, A.L.M., Rodrigo, E., Cotorruelo, J.G., Zubimendi, J.A., Ruiz, J.C., Pinera, C., Herraez, I., Arias, M.: Clinical Relevance of Posttransplantation HLA Antibody Monitoring by ELISATransplant-Proc. 35: 701 (2003)

123.Al-Hussein, K.A.., Shenton, B.K., Bell, A., Talbot, D., Clark, K.R., Rigg, K.M., Forsythe, J.L.R., Proud, G., Taylor, R.M.R.: Characterization of donor-directed antibody class in the post-transplant period using flow cytometry in renal transplantationTranspl Int. 7: 182-189 (1994)

124.Sengar, D.P.S., Couture, R.A., Bell, R.C., Lazarovits, A.I., Jindal, S.L.: Deleterious effect of T- and B-cell panel antibodies and donor-specific B-cell crossmatches on cadaveric renal allograft survivalClin Transplantation 4: 112-116 (1990)

125.Kerman, R.H., Susskind, B., Buelow, R., Regan, J., Pouletty, P., Williams, J., Gerolami, K., Kerman, D.H., Katz, S.M., Van Buren, C.T., Kahan, B.D.: Correlation of ELISA-Detected IgG and IgA Anti-HLA Antibodies in Pretransplant sera with renal allograft RejectionTransplantation 62: 201-205 (1996)

126.Lavee, J., Kormos, R.L., Duquesnoy, R.J., Zerbe, T.R., Armitage, J.M., Vanek, M., Hardesty, R.L., Griffith, B.P.: Influence of Panel-reactive Antibody and Lymphocytotoxic Crossmatch on Survival after Heart TransplantationJ-Heart-Lung-Transplant. 6: 921-929 (1991)

127.Monteiro, F., Mineiro, C., Rodrigues, H., de Paula, F.J., Kalil, J.: Pretransplant and Posttransplant Monitoring of Anti-HLA Class I IgG1 Antibodies by ELISA Identifies Patients at High Risk of Graft LossTransplant-Proc. 29: 1433-1434 (1997)

128.Süsal, C., Opelz, G.: Kidney Graft Failure and Presensitization against HLA Class I and Class II AntigensTransplantation 73: 1269-1273 (2002)

129.Piazza, A., Torlone, N., Valeri, M., Poggi, E., Monaco, P.I., Provenzani, L., Tisone, G., Adorno, D., Casciani, C.U .: Antidonor-HLA Antibodies and Soluble HLA Antigens after Kidney TransplantTransplant-Proc. 25: 3279-3280 (1993)

130.Buchler, M., Al Najjar, A., Guerraoui, A., Valentin, J.F., Boulanger, M.D., Sherobeen, R., Lataste, A., Nivet, H., Lebranchu, Y.: Posttransplant Anti-HLA Antibodies: Risk Factor for Chronic RejectionTransplant-Proc. 27: 2478-2479 (1995)

131.Barr, M.L., Cohen, D.J., Benvenisty, A.I., Hardy, M., Reemtsma, K., Rose, E.A., Marboe, C.C., D´Agati, V., Suciu-Foca, N., Reed, E .: Effect of Anti-HLA Antibodies on the Long-Term Survival of Heart and Kidney AllograftsTransplant-Proc. 25: 262-264 (1993)

132.Kerman, R.H., Susskind, B., Kerman, D.H., Lam, M., Gerolami, K., Williams, J., Kalish, R., Campbell, M., Katz, S.M., Van Buren, C.T., Kahan, B.D.: Anti-HLA Antibodies Detected in Posttransplant Renal Allograft Recipient Sera Correlate with Chronic RejectionTransplant-Proc. 29: 1515-1516 (1997)

133.Deka, R., Panigrahi, A., Aggarwal, S.K., Guleria, S., Dash, S.C., Mehta, S.N., Pandey, R.M., Mehra, N.K .: Influence of Pretransplant Panel Reactive Antibodies on the Posttransplant Sensitization StatusTransplant-Proc. 34: 3082-3083 (2002)

134.Lobo, P.I., Spencer, C., Douglas, M.T., Stevenson, W.C., Pruett, T.L.: The Lack of Long-Term Detrimental Effects on Liver Allografts Caused by Donor-Specific Anti-HLA AntibodiesTransplantation 55: 1063-1066 (1993)

135.Groth, J., Knijnenburg, C., Kaden, J., Strobelt, V., May, G.: Serologische Untersuchungen an Patienten mit frühem Transplantatversagen
Z Urol Nephrol 79: 405-409 (1986)

136.Leverenz, S., Krause, I.K., Schönemann, C., Schirmer, R., Strobelt, V., May, G.: Bewertung der HLA-Kompatibilität bei Nierentransplantation unter Berücksichtigung des Auftretens lymphozytotoxischer HLA-Antikörper nach Bluttransfusionen und Transplantationen
Tx Med 8: 54-66 (1996)

137.Lamm, L.U., Graugaard, B., Kissmeyer, F .: Kidney Transplantation in Highly Sensitized PatientsTransplant-Proc. 18: 18-19 (1986)

138.Ogura, K., Terasaki, P.I., Johnson, C., Mendez, R., Rosenthal, J.T., Ettenger, R., Martin, D.C., Dainko, E., Cohen, L., Mackett, T., Berne, T., Barba, L., Liebermann, E.: The Significance of a Positive Flow Cytometry Crossmatch Test in primary Kidney TransplantationTransplantation 56: 294-298 (1993)

139.Terasaki, P.I., Takemoto, S., Park, M.S., Clark, B .: Landsteiner Award. HLA epitope matchingTransfusion 32: 775-786 (1992)

140.Martin, S., Conolly, J., Jos, V.: Importance of HLA Matching in Highly Sensitised Renal Transplant Recipients with High Transplant Survival RatesTransplant-Proc. 25: 265-266 (1993)

141.Ghobrial, I.I., Morris, A.G., Booth, L.J .: Clinical significance of in vitro donor-specific hyporesponsiveness in renal allograft recipients as demonstrated by the MLRTranspl Int 7: 420-427 (1994)

142.Reinsmoen, N.L., Hertz, M.I., Kubo, S., Bolman, R.M., Matas, A.J.: Immun Factors Correlating with Improved Long-Term Graft Outcome in Kidney, Lung, and Heart TransplantsTransplant-Proc. 25: 3277-3278 (1993)

143.Reinsmoen, N.L., Matas, A.J .: Evidence that improved Late Renal Transplant Outcome Correlates with the Development of In Vitro Donor Antigen-Specific HyporeactivityTransplantation 55: 1017-1023 (1993)

144.Kerman, R.H., Katz, S.M., Schoenberg, L., Baraket, O., Van Buren, C.T., Kahan, B.D.: Ten-Year Follow-Up of Mixed Lymphocyte Reaction-Hyporesponsive Living Related Cyclosporine Monotherapy-Treated Renal Allograft RecipientsTransplant-Proc. 29: 198-199 (1997)

145.Knoop, M., Neumann, U., Neuhaus, P.: Immunologische Toleranz nach experimenteller Lebertransplantation
Langenbecks Arch Chir380: 281-287 (1995)

146.Lantz, O., Alard, P., Ben Aribia, M.H., Chavanel, G., Fries, D., Senik, A., Charpentier, B.: Persistence of Donor-Specific IL-2-Secreting Cells and Cytotoxic T Lymphocyte Precursors in Human Kidney Transplant Recipients Evidenced by Limiting Dilution AnalysisJ-Immunol. 144: 3748-3755 (1990)

147.Yang, L., DuTemple, B., Khan, Q., Zhang, L .: Mechanisms of Long-Term Donor-Specific Allograft Survival Induced by Pretransplant Infusion of LymphocytesBlood 91: 324-330 (1998)

148.Kerman, R.H., Susskind, B., Katz, S.M., Van Buren, C.T., Kahan, B.D .: Postrenal Transplant MLR Hypo-Responders Have Fewer Rejections and Better Graft Survival Than MLR Hyper-RespondersTransplant-Proc. 29: 1410-1411 (1997)

149.Propper, D.J., Stewart, K.N., Catto, G.R.D., MacLeod, A.M., Power, D.A.: Relative Effects of Major and Minor Histocompatibility Locus Antigens on the Generation of Suppressor Activity by Blood TransfusionsTransplant-Proc. 23: 437-440 (1991)

150.Kahan, B.D., Kerman, R.H., Van Buren, C.T., Flechner, S.M., Golden, D.L., Lewis, R.M.: Clinical Outcome in 36 Patients after at least One up to 5 Years of Steroid Withdrawal Based upon Specific Mixed Lymphocyte Reaction Hyporesponsiveness Toward the Living Related DonorTransplant-Proc. 21: 1579-1580 (1989)


© Die inhaltliche Zusammenstellung und Aufmachung dieser Publikation sowie die elektronische Verarbeitung sind urheberrechtlich geschützt. Jede Verwertung, die nicht ausdrücklich vom Urheberrechtsgesetz zugelassen ist, bedarf der vorherigen Zustimmung. Das gilt insbesondere für die Vervielfältigung, die Bearbeitung und Einspeicherung und Verarbeitung in elektronische Systeme.
DiML DTD Version 4.0Zertifizierter Dokumentenserver
der Humboldt-Universität zu Berlin
HTML-Version erstellt am:
27.05.2005